Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 7961-7970 of 12128

Page
per page
  1. Flumatinib mesylate
    A8691 Flumatinib mesylate
    Summary: PDGRFβ inhibitor
      Soluble in DMSO
  2. AKT/mTOR Set I
    A9904 AKT/mTOR Set I
    Summary: For inhibiting AKT/mTOR
  3. TG003
    B1431 TG003
    Target: Cdc2-like kinase (Clk)
    Summary: Cdc2-like kinase (Clk) inhibitor
      insoluble in H2O; ≥12.45 mg/mL
  4. OSI-027
    B1637 OSI-027
    Summary: MTORC1/ mTORC2 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥32.5 mg/mL
  5. SB590885
    B1406 SB590885
     1 Citation
    Summary: Potent B-Raf inhibitor
      insoluble in H2O; insoluble in EtOH; ≥4.54 mg/mL
  6. Cabozantinib malate (XL184)
    B1401 Cabozantinib malate (XL184)
    Summary: MET andVEGF receptor2 inhibitor
      ≥31.8 mg/mL
  7. IDE 2
    B5511 IDE 2
    Summary: inducer of definitive endoderm formation
      Soluble in DMSO
  8. VU 0285683
    B5569 VU 0285683
    Summary: negative allosteric modulator of mGlu5 receptors
      <6.66 mg/mL
  9. TC-G 1004
    B5580 TC-G 1004
    Summary: adenosine A2A receptors antagonist
  10. MK 0343
    B5585 MK 0343
    Summary: GABAA partial agonist
      <39.74 mg/mL

Items 7961-7970 of 12128

Page
per page